Stay updated on NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change likely pertains to medical and healthcare-related publications and documentation.
    Difference
    58%
    Check dated 2024-05-22T08:50:54.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    16 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change likely indicates an update or revision in the estimated primary completion date for the medical study involving NKTR-214 and nivolumab in patients with metastatic and/or locally advanced sarcoma.
    Difference
    0.0%
    Check dated 2024-05-10T08:44:35.000Z thumbnail image
  7. Check
    17 days ago
    Change Detected
    Summary
    The value on the webpage related to a study of NKTR-214 and Nivolumab in patients with metastatic and/or locally advanced sarcoma has been updated from an estimated primary completion date of 2024-05-08 to 2025-09. This change likely reflects a shift in the timeline for the study's completion and potential impact on the availability of results and findings.
    Difference
    1%
    Check dated 2024-05-09T06:24:29.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T23:24:23.000Z thumbnail image

Stay in the know with updates to NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.